Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)

Summary

This is an additional list of diagnostic testing-related protocols, further to the Cochrane Dementia and Cognitive Improvement Group (CDCIG) Diagnostic Test Accuracy (DTA) protocols and protocol templates listed earlier in Generic Protocol(s) for Diagnostic Test Accuracy Reviews in Dementia (Cochrane Database).

These reviews of various neuropsychological tests are part of the National Institute for Health Research (NIHR) Cochrane Collaboration Programme.

Concerning the use of 11C-PIB-PET for the early diagnosis of Alzheimer’s Disease and other dementias in people with mild cognitive impairment (MCI):

Full Text Link

Reference

Zhang, S. Smailagic, N. [and] Hyde, C. [et al] (2014). 11C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews. July 23rd 2014, Issue 7. No. CD010386.

Concerning the use of AD-8 for diagnosis of dementia in various healthcare settings:

Full Text Link

Reference

Hendry, K. Leesm RA, [and] McShane, R. [et al] (2014). AD-8 for diagnosis of dementia across a variety of healthcare settings (Protocol). Cochrane Database of Systematic Reviews. May 19th 2014, Issue 5. No. CD011121.

Concerning use of the APOE-4 allele for the diagnosis of Alzheimer’s Disease and other dementia disorders in people with mild cognitive impairment in primary care:

Full Text Link

Reference

Elias-Sonnenschein, LS. Viechtbauer, W. [and] Ramakers, I. [et al] (2014). APOE-ε4 allele for the diagnosis of Alzheimer’s and other dementia disorders in people with mild cognitive impairment in a primary care setting (Protocol). Cochrane Database of Systematic Reviews. January 31st 2014, Issue 1. No. CD010949.

Concerning use of the APOE-4 allele for the diagnosis of Alzheimer’s Disease and other dementias in people with mild cognitive impairment in secondary care settings:

Full Text Link

Reference

Elias-Sonnenschein, LS. Viechtbauer, W. [and] Ramakers, I. [et al] (2014). APOE-ε4 allele for the diagnosis of Alzheimer’s and other dementia disorders in people with mild cognitive impairment in a secondary care setting (Protocol). Cochrane Database of Systematic Reviews. January 31st 2014, Issue 1. No. CD010950.

Concerning use of the APOE-4 allele for the diagnosis of Alzheimer’s Disease and other dementias in people with mild cognitive impairment in community settings:

Full Text Link

Reference

Elias-Sonnenschein, LS. Viechtbauer, W. [and] Ramakers, I. [et al] (2014). APOE-ε4 allele for the diagnosis of Alzheimer’s and other dementia disorders in people with mild cognitive impairment in a community setting (Protocol). Cochrane Database of Systematic Reviews. January 31st 2014, Issue 1. No. CD010948.

Concerning the use of Plasma and Cerebrospinal Fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer’s Disease in participants previously diagnosed with dementia in specialist care settings:

Full Text Link

Reference

Kokkinou, M. Smailagic, N. [and] Noel-Storr, AH. [et al] (2014). Plasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer’s Disease dementia in participants diagnosed with any dementia subtype in a specialist care setting (Protocol). Cochrane Database of Systematic Reviews. January 31st 2014, Issue 1. No. CD010945.

A possibly related systematic review on the use of this testing technology for people with mild cognitive impairment has been published more recently: see Diagnosis, Screening, Assessment and Symptoms-Related Systematic Reviews and Meta-Analyses.

Concerning the use of rCBF SPECT for detecting frontotemporal dementia in people with suspected dementia:

Full Text Link

Reference

Coulthard, EJ. Archer, HA. [and] Smailagic, N. [et al] (2014). rCBF SPECT for detection of frontotemporal dementia in people with suspected dementia (Protocol). Cochrane Database of Systematic Reviews. December 23rd 2013, Issue 12. No. CD010896.

Concerning the use of Mini-Cog for diagnosis of Alzheimer’s Disease and other dementias in community settings:

Full Text Link

Reference

Fage, BA. Seitz, DP. [and] Gill, SS. [et al] (2014). Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting (Protocol). Cochrane Database of Systematic Reviews. November 29th 2013, Issue 11. No. CD010860.

Concerning the use of CSF Tau and the CSF Tau / ABeta Ratio for the diagnosis of Alzheimer’s Disease and other dementias in people with mild cognitive impairment (MCI):

Full Text Link

Reference

Ritchie, C. Smailagic, N. [and] Ladds, EC. [et al] (2014). CSF tau and the CSF tau / ABeta ratio for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) (Protocol). Cochrane Database of Systematic Reviews. Oct 26th 2013, Issue 10. No. CD010803.

Concerning the use of IQCODE for the diagnosis of Alzheimer’s Disease and other dementias in general practice (primary care) settings, a more recent systematic review has been published: see Diagnosis, Screening, Assessment and Symptoms-Related Systematic Reviews and Meta-Analyses.

Concerning the use of IQCODE for the diagnosis of Alzheimer’s Disease and other dementias in secondary care settings, a more recent systematic review has been published: see Diagnosis, Screening, Assessment and Symptoms-Related Systematic Reviews and Meta-Analyses.

Concerning dopamine transporter imaging for the diagnosis of dementia with Lewy bodies:

Full Text Link

Reference

McCleery, J. Morgan, S. [and] Hyde, C. [et al] (2014). Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies (Protocol). Cochrane Database of Systematic Reviews. July 10th 2013, Issue 7. No. CD010633.

Concerning the accuracy of 18FDG-PET in the early diagnosis of Alzheimer’s Disease and other dementias in people with MCI:

Full Text Link

Reference

Vacante, M. Smailagic, N. [and] Sachpekidis, C. [et al] (2014). The accuracy of 18FDG-PET in the early diagnosis of Alzheimer’s Disease dementia and other dementias in people with MCI (Protocol). Cochrane Database of Systematic Reviews. July 5th 2013, Issue 7. No. CD010632.

Concerning the role of MRI in the early diagnosis of Alzheimer’s Disease or other dementias in persons with mild cognitive impairment (MCI):

Full Text Link

Reference

Filippini, G. Casazza, G. [and] Bellatorre, AG. [et al] (2014). The role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI) (Protocol). Cochrane Database of Systematic Reviews. February 15th 2012, Issue 2. No. CD009628.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Models of Dementia Care, NIHR, Systematic Reviews, UK and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.